Publication | Open Access

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Multidrug-resistant VirusTreatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyVirologyTreatment-experienced PatientsPharmacotherapyAntiviral DrugHivMedicinePhase IiDrug Resistance